Investing

Compass Therapeutics : CMPX

CMPX

Stock Data

$2.02

$0.04 (1.94%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Compass Therapeutics Inc is a biopharmaceutical company focused on creating innovative antibody therapies for cancer treatment. Based in Boston, Massachusetts, since 2014, it pioneers in developing drugs like CTX-009, CTX-471, and CTX-8371, targeting critical pathways and receptors involved in tumor growth and immune response. Their research aims to unlock new possibilities in oncology, offering hope for better, more effective treatments.

All Compass Therapeutics Articles

1 Article

Lee Jackson | Dec 3, 2025 at 8:15 AM EST

Here Are Wednesday’s Top Wall Street Analyst Upgrades and Downgrades: American Eagle Outfitters, Equinix, Garmin, Honeywell, Uber, Wendy’s and More

Pre-Market Stock Futures: Futures are trading lower on Wednesday after an ADP report showing job losses, following a stellar day…